Cite
D'Arena G, Guariglia R, Mansueto G, et al. No cross-resistance after sequential use of romiplostim and eltrombopag in chronic immune thrombocytopenic purpura. Blood. 2013;121(7):1240-1242
MLA
Giovanni D’Arena, et al. “D’Arena G, Guariglia R, Mansueto G, et Al. No Cross-Resistance after Sequential Use of Romiplostim and Eltrombopag in Chronic Immune Thrombocytopenic Purpura. Blood. 2013;121(7):1240-1242.” Blood, vol. 123, Mar. 2014, p. 1971. EBSCOhost, https://doi.org/10.1182/blood-2014-01-553768.
APA
Giovanni D’Arena, Roberto Guariglia, & Giovanna Mansueto. (2014). D’Arena G, Guariglia R, Mansueto G, et al. No cross-resistance after sequential use of romiplostim and eltrombopag in chronic immune thrombocytopenic purpura. Blood. 2013;121(7):1240-1242. Blood, 123, 1971. https://doi.org/10.1182/blood-2014-01-553768
Chicago
Giovanni D’Arena, Roberto Guariglia, and Giovanna Mansueto. 2014. “D’Arena G, Guariglia R, Mansueto G, et Al. No Cross-Resistance after Sequential Use of Romiplostim and Eltrombopag in Chronic Immune Thrombocytopenic Purpura. Blood. 2013;121(7):1240-1242.” Blood 123 (March): 1971. doi:10.1182/blood-2014-01-553768.